BIOGRAD BIOBANK LIMITED

13753693
Active United Kingdom

Other letting and operating of own or leased real estate

2 employees website.com
Life sciences and medical technology Other letting and operating of own or leased real estate
B

BIOGRAD BIOBANK LIMITED

13753693

Other letting and operating of own or leased real estate

Founded 19 Nov 2021 Active United Kingdom 2 employees website.com
Life sciences and medical technology Other letting and operating of own or leased real estate

Previous Company Names

BIOGRAD INNOVATION CENTRE LIMITED 16 Aug 2022 — 30 Aug 2022
TUTUM PROPERTY LIMITED 19 Nov 2021 — 16 Aug 2022
Accounts Submitted 26 Jun 2025 Next due 29 Jun 2026 4 days overdue
Confirmation Submitted 2 Feb 2026 Next due 2 Dec 2026 5 months remaining
Net assets £1M £35K 2024 year on year
Total assets £2M £68K 2024 year on year
Total Liabilities £713K £33K 2024 year on year
Charges 2
2 outstanding

Contact & Details

Contact

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for BIOGRAD BIOBANK LIMITED (13753693), an active life sciences and medical technology company based in United Kingdom. Incorporated 19 Nov 2021. Other letting and operating of own or leased real estate. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 30 Sept → 29 Sept 2024
Type micro-entity
Next accounts 29 Sept 2025
Due by 29 Jun 2026 1 month overdue

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

N/A

Net Assets

£1.22M

Decreased by £34.79k (-3%)

Total Liabilities

£712.64k

Decreased by £32.92k (-4%)

Turnover

N/A

Employees

2

Debt Ratio

37%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
29 Sept Year End
2023
30 Sept Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active
Status
Matthew FaganDirectorBritishUnited Kingdom4619 Nov 2021Active
Natalie KennyDirectorBritishUnited Kingdom4419 Nov 2021Active

Shareholders

Shareholders (2)

Natalie Kenny
90.0%
Matthew Fagan
10.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Natalie Kenny

British

Active
Notified 19 Nov 2021
Residence United Kingdom
DOB July 1982
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

2 outstanding

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
61 Stephenson Way, Wavertree, Liverpool (L13 1HN) LIVERPOOL
Leasehold£950,00021 Jun 2022
61 Stephenson Way, Wavertree, Liverpool (L13 1HN)
Leasehold £950,000
Added 21 Jun 2022
District LIVERPOOL

Documents

Company Filings

DateCategoryDescriptionDocument
2 Feb 2026OfficersChange to director Dr Natalie Kenny on 2 Feb 2026
2 Feb 2026Confirmation StatementConfirmation statement made on 18 Nov 2025 with no updates
2 Feb 2026Persons With Significant ControlChange to Dr Natalie Kenny as a person with significant control on 2 Feb 2026
26 Jun 2025AccountsAnnual accounts made up to 29 Sept 2024
22 Apr 2025AddressChange Registered Office Address Company With Date Old Address New Address
2 Feb 2026 Officers

Change to director Dr Natalie Kenny on 2 Feb 2026

2 Feb 2026 Confirmation Statement

Confirmation statement made on 18 Nov 2025 with no updates

2 Feb 2026 Persons With Significant Control

Change to Dr Natalie Kenny as a person with significant control on 2 Feb 2026

26 Jun 2025 Accounts

Annual accounts made up to 29 Sept 2024

22 Apr 2025 Address

Change Registered Office Address Company With Date Old Address New Address

Recent Activity

Latest Activity

Change to director Dr Natalie Kenny on 2 Feb 2026

5 months ago on 2 Feb 2026

Confirmation statement made on 18 Nov 2025 with no updates

5 months ago on 2 Feb 2026

Change to Dr Natalie Kenny as a person with significant control on 2 Feb 2026

5 months ago on 2 Feb 2026

Annual accounts made up to 29 Sept 2024

1 years ago on 26 Jun 2025

Change Registered Office Address Company With Date Old Address New Address

1 years ago on 22 Apr 2025